comparemela.com

Latest Breaking News On - Fascinate therapeutics inc - Page 1 : comparemela.com

FAScinate Therapeutics Completes Part 1a of Phase 2 Study of Company s Parkinson s Disease Drug Candidate KM-819

San Diego, CA (PRWEB) January 11, 2023 Clinical stage drug development company FAScinate Therapeutics, Inc. today announced the successful completion of

United statesSan diegoFascinate therapeutics incCompany parkinson diseaseKainos medicine incTherapeutics incKorean biotechKainos medicinePress release

Egret Therapeutics completes oversubscribed pre-A financing round

/PRNewswire/ Egret Therapeutics, a clinical-stage biotherapeutics company focused on the treatment of neurological diseases, announced today the completion.

Jaemoon leeDaniel chaiChristopher jacksonFascinate therapeutics incChairperson of neurosurgery at stanford medical centerEgret therapeuticsTurret capital managementDelayed cerebral ischemiaTurret capitalMichael limStanford medical centerAssistant professorJohns hopkins medicalHealth care amp hospitalsMedical pharmaceuticalsFinancing agreements

Egret Therapeutics completes oversubscribed pre-A financing round

/PRNewswire/ Egret Therapeutics, a clinical-stage biotherapeutics company focused on the treatment of neurological diseases, announced today the completion.

Jaemoon leeDaniel chaiChristopher jacksonFascinate therapeutics incChairperson of neurosurgery at stanford medical centerEgret therapeuticsTurret capital managementDelayed cerebral ischemiaTurret capitalMichael limStanford medical centerAssistant professorJohns hopkins medical

FAScinate Therapeutics Inc Submits Investigational New Drug (IND) Application for Phase 2 Clinical Studies of Company s New Parkinson s Disease Treatment

SAN DIEGO, CA (PRWEB) November 02, 2021 FAScinate Therapeutics today announced that it has submitted an Investigational New Drug (IND) Application for

United statesSan diegoFascinate therapeutics incDrug administrationKainos medicine incInvestigational new drugTherapeutics incKorean biotechKainos medicineLooking statementsPress release

vimarsana © 2020. All Rights Reserved.